Yun-Yi Xie
Biographic Data
| ID | 10434086 |
|---|---|
| NAME | Yun-Yi Xie |
| GIVEN NAMES | Yun-Yi |
| FAMILY NAME | Xie |
| SIGNATURE | XIE Y |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The prevalence of disability and associated factors among community adults in the baseline of CHCN-BTH Cohort Study
ChiCTR1900024725 (25/07/2019)
Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia
Aripiprazole, metformin, and paeoniae-glycyrrhiza decoction (PGD) have been widely used as adjunctive treatments to reduce antipsychotic (AP)-induced hyperprolactinemia in patients with schizophrenia. However, the comparative efficacy and safety of these medications have not been previously studied. A network meta-analysis of randomized controlled trials (RCTs) was conducted to compare the efficacy and safety between aripiprazole, metformin, and …
No prominent works on this page.
Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia
Aripiprazole, metformin, and paeoniae-glycyrrhiza decoction (PGD) have been widely used as adjunctive treatments to reduce antipsychotic (AP)-induced hyperprolactinemia in patients with schizophrenia. However, the comparative efficacy and safety of these medications have not been previously studied. A network meta-analysis of randomized controlled trials (RCTs) was conducted to compare the efficacy and safety between aripiprazole, metformin, and …
The prevalence of disability and associated factors among community adults in the baseline of CHCN-BTH Cohort Study
ChiCTR1900024725 (25/07/2019)
Medicine (2 works) · Adjunctive treatment (1 work) · Adverse effect (1 work) · Amisulpride (1 work) · Antipsychotic (1 work) · Aripiprazole (1 work) · Atypical antipsychotic (1 work) · Biostatistics (1 work) · Chronic Disease Management Strategies (1 work) · Cohort (1 work)